Tel Aviv University researchers have discovered an “extremely effective way” to prevent the spread of breast cancer to other parts of the body in mice by combining gene therapy with chemotherapy and delivering it to the tumor.
By combining gene therapy with chemotherapy and delivering it to a primary tumor site, researchers at Tel Aviv University’s Sackler Faculty of Medicine have discovered in mice an “extremely effective way” to prevent the spread of breast cancer to other parts of the body.Doctor [Illustrative] – Photo: INGIMAGE
One in eight women worldwide contract breast cancer, making it the second leading cause of cancer death in women. Continue Reading »
Currently, Jewish women are only tested for the BRCA1 & BRCA2 gene mutations if they report high incidences of cancer among their female relatives.
All Ashkenazi Jewish women should be routinely tested for two genetic mutations, even if they do not have a family history of breast cancer, a leading researcher said in an article published on Friday.
A patient and a technician during mammogram screening. – Photo: AP
The connection between harmful mutations in the tumor suppressor genes BRCA1 and BRCA2 and hereditary breast-ovarian cancer is well-established, but women are typically only screened if they report high incidences of cancer among close female relatives. Continue Reading »
American readers were offended by the paper’s controversial front page photo citing partial nudity & Jewish tradition as cause.
An unnamed Israeli woman pictured in a controversial photo on the front page of The New York Times on Wednesday spoke out in response to critics of the paper’s choice of images.
The front page of The New York Times Wednesday.- Photo Courtesy NYT
An image of the woman’s upper body – including an incision scar, a portion of her areola and a Star of David tattoo – was featured as the lead photo in the paper that day to illustrate a story about breast cancer screening in Israel. Continue Reading »
Cryoablation, a process which uses extreme cold to freeze and destroy diseased tissue, has been used by medical experts for years to treat both malignant and benign tumors, mostly in the kidneys and prostate.
IceCure - Health News - Israel - Photo: IceCure Medical
An Israeli biomedical company, IceCure Medical, has taken the technology into the field of breast tumors. Their system, called IceSense3, has been specifically developed to treat fibroadenomas, which are the most common type of benign breast tumors, typically seen in young women aged 15 to 30.
The system is currently being used worldwide for treatment of the benign lumps, but now also holds promise as a potential treatment option for malignant breast tumors, after a successful clinical trial on four women in Japan. Continue Reading »